Sheryl Stevenson

Sheryl Stevenson is editorial director of Ophthalmology Times, Ophthalmology Times Europe, Modern Retina and Optometry Times.

Articles by Sheryl Stevenson

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025

ByBriana Contreras,Sydney Crago,Sheryl Stevenson

October 21st 2025

New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.

Will Payers Be an Obstacle to the ‘Epi-On’ Approach to Corneal Collagen Crosslinking? | AAO 2025

ByPeter Wehrwein, Managing Editor,Logan Lutton,Sheryl Stevenson,Sydney Crago

October 20th 2025

The Advantages of ‘Epi-On’ Over ‘Epi-Off’ Treatment of Keratoconus | AAO 2025

ByPeter Wehrwein, Managing Editor,Logan Lutton,Sheryl Stevenson,Sydney Crago

October 20th 2025

Understanding Keratoconus and Its Early Treatment | AAO 2025

ByPeter Wehrwein, Managing Editor,Logan Lutton,Sheryl Stevenson,Sydney Crago

October 20th 2025

Sheryl Stevenson

Articles by Sheryl Stevenson

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025

Will Payers Be an Obstacle to the ‘Epi-On’ Approach to Corneal Collagen Crosslinking? | AAO 2025

The Advantages of ‘Epi-On’ Over ‘Epi-Off’ Treatment of Keratoconus | AAO 2025

Understanding Keratoconus and Its Early Treatment | AAO 2025

Latest Updated Articles

Trending on Managed Healthcare Executive

Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access

Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma

Key Takeaways, Study Limitations, and the Broader Implications of CROWN for Patients, Providers, and Payers